2025-11-24 - Analysis Report
Okay, here's a comprehensive analysis of Sempra (SRE) based on the provided data.

**1) Return Comparison (SRE vs. VOO):**

*   **Sempra (SRE) Overview:** Sempra is an energy infrastructure company focused on electric and gas services.
*   **SRE Cumulative Return:** 19.60%
*   **VOO (S&P 500) Cumulative Return:** 94.64%
*   **Divergence:** -75.0 (Relative Divergence: 16.4)

**Analysis:** Sempra has significantly underperformed the S&P 500 over the period examined. The negative divergence of -75.0 indicates a substantial difference in cumulative return compared to VOO.  A relative divergence of 16.4 suggests this underperformance is near the lowest end of its historical range relative to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha   | Beta   | Cap(B) |
|------------|--------|-------|---------|--------|--------|
| 2015-2017  | 8.0%   | 70.6% | -19.0%  | 0.1    | 34.9   |
| 2016-2018  | 11.0%  | 71.1% | -5.0%   | 0.1    | 35.3   |
| 2017-2019  | 35.0%  | 71.1% | 13.0%   | 0.2    | 49.4   |
| 2018-2020  | -4.0%  | 80.1% | -28.0%  | 0.2    | 41.6   |
| 2019-2021  | -2.0%  | 80.1% | -49.0%  | 0.4    | 43.2   |
| 2020-2022  | -15.0% | 81.1% | -14.0%  | 0.4    | 50.4   |
| 2021-2023  | 22.0%  | 81.1% | 20.0%   | 0.5    | 48.8   |
| 2022-2024  | 11.0%  | 81.1% | -10.0%  | 0.6    | 57.2   |
| 2023-2025  | -10.0% | 74.5% | -69.0%  | -0.2   | 60.4   |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate fluctuates, with significant volatility.
*   **MDD:** The Maximum Drawdown is consistently high, indicating periods of significant losses.
*   **Alpha:** Alpha is mostly negative, suggesting SRE is underperforming its benchmark (likely the S&P 500) on a risk-adjusted basis.  There are some periods of positive Alpha (2017-2019, 2021-2023).
*   **Beta:** Beta is generally low (around 0.1 to 0.6), indicating SRE's price is less volatile than the market (S&P 500). The recent beta has decreased to -0.2.
*   **Cap:** The company's market capitalization has been increasing over the years.

**2) Recent Stock Price Fluctuations:**

*   **Current Price:** 92.5
*   **Previous Close:** 90.71
*   **Change:** 1.97
*   **5-day SMA:** 91.61
*   **20-day SMA:** 92.40
*   **60-day SMA:** 89.01

**Analysis:** The current price is slightly above the 20-day SMA, suggesting a short-term upward trend. The 5-day SMA is slightly below the 20-day SMA. Also note that the previous close increased sharply.

**3) Technical Indicators:**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 49.52 (Neutral - neither overbought nor oversold)
*   **PPO:** -0.35 (Slightly bearish trend)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (23 shares - Very Safe - MRI:0.90) Dividend_0.65 Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-10-01)
*   **Recent (20 days) Relative Divergence Change:** 4.2 (+) 단기상승 (Short-term increase)
*   **Expected Return (%):** -167.9

**Analysis:**

*   The MRI suggests a medium level of investment risk.
*   The RSI is neutral.
*   PPO indicates a slightly bearish trend.
*   The Hybrid Signal is recommending a strong "Buy" signal, however with MRI = 0.90.
*   Recent increase in relative divergence suggests positive short-term performance compared to its benchmark.
*   The negative expected return indicates that the model predicts further underperformance compared to the S&P 500.

**4) Recent News & Significant Events:**

*   **Positive:** Sempra tops quarterly profit estimates.
*   **Neutral:** SoCalGas announces dividend, Swiss National Bank Acquires Shares.
*   **Negative:** SCCM Value Equity Fund Sold Sempra shares, Insider Sale, Concerns about undervaluation.

**Analysis:** The news is mixed. While earnings estimates are positive and a dividend has been announced, fund selling and insider sales create negative sentiment. There is discussion of whether SRE is undervalued.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (~1.82)
*   **Target Price (avg/high/low):** 99.07 / 115.00 / 80.00

**Analysis:**  Analysts generally have a positive outlook on SRE, with a "Buy" consensus and an average target price above the current price. However, there's a wide range in target prices, indicating uncertainty.

**5) Recent Earnings Analysis:**

| 날짜       | EPS   | 매출     |
|------------|-------|----------|
| 2025-11-05 | 0.12  | 2.76 B$  |
| 2025-08-07 | 0.71  | 2.70 B$  |
| 2025-05-08 | 1.39  | 3.68 B$  |
| 2024-11-06 | 1.01  | 2.57 B$  |
| 2025-11-05 | 1.01  | 2.57 B$  |

**Analysis:** EPS and Revenue have been quite variable.  The most recent EPS is lower than previous quarters. Revenues have also fluctuated, with the highest revenue in 2025-05-08.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-09-30   | $3.15B  | 42.94%        |
| 2025-06-30   | $3.00B  | 46.73%        |
| 2025-03-31   | $3.80B  | 47.21%        |
| 2024-12-31   | $3.76B  | 49.23%        |
| 2024-09-30   | $2.78B  | 44.49%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE     |
|--------------|----------|---------|
| 2025-09-30   | $31.17B  | 0.30%   |
| 2025-06-30   | $31.72B  | 1.49%   |
| 2025-03-31   | $31.66B  | 2.90%   |
| 2024-12-31   | $31.24B  | 2.16%   |
| 2024-09-30   | $29.72B  | 2.18%   |

**Analysis:**

*   **Revenue:** Revenue has fluctuated.
*   **Profit Margin:** Profit margins are relatively high, but has recently decreased in 2025-09-30.
*   **Equity:** Equity has generally been increasing.
*   **ROE:** ROE is very low in the most recent quarter.

**7) Comprehensive Analysis (Summary):**

Sempra (SRE) has significantly underperformed the S&P 500. While analysts have a generally positive outlook ("Buy"), the technical indicators present a mixed picture.  The recent increase in price is a positive sign, but negative news events (fund selling, insider sales) and the negative expected return raise concerns. ROE has also significantly decreased. While it is considered a very safe investment given a "Buy" signal. The MRI has decreased over time, suggesting there is an increasing risk to investment in the company. Investors should carefully consider these factors and their own risk tolerance before investing in Sempra.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.